Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
Multiple Sclerosis and Related Disorders|July 30, 2023
Disease-modifying therapies do not affect sleep quality or daytime sleepiness in a large Australian MS cohortJason A Turner, Laura L Laslett, Christine Padgett, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 22, 2017
An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating eventPrudence Tettey, Steve Simpson, Bruce Taylor, et al.Nature Communications|September 25, 2021
Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseasesYuanhao Yang, Hannah Musco, Steve Simpson-Yap, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosisJing Chen, Bruce Taylor, Andrew J Palmer, et al.Addiction (Abingdon, England)|October 21, 2024
Public perceptions of opioid misuse recovery and related resources in a nationally representative sample of United States adultsOlivia Golan, Alex Kresovich, Christina Drymon, et al.Annals of Neurology|August 10, 2010
Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosisSteve Simpson, Bruce Taylor, Leigh Blizzard, et al.International Journal of Environmental Research and Public Health|March 11, 2023
A National Portrait of Public Attitudes toward Opioid Use in the US: A Latent Class AnalysisSuzan M Walters, Weiwei Liu, Phoebe Lamuda, et al.Multiple Sclerosis and Related Disorders|July 13, 2023
Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022Steve Simpson-Yap, Duncan Maddox, Jeanette Reece, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 16, 2011
Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosisSteve Simpson, Bruce Taylor, Dominic E Dwyer, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2018
Polymorphism in the serotonin transporter gene polymorphisms ( 5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosisAlice Saul, Bruce Taylor, Steve Simpson, et al.Pageof 16